Japan to Cut Price of Alzheimer's Drug Lecanemab
Japan to Cut Price of Alzheimer's Drug Lecanemab
Tokyo, July 10 (Jiji Press)--Japan is expected to lower the price of lecanemab, an Alzheimer's drug codeveloped by Japanese drugmaker Eisai Co. and Biogen Inc. of the United States, following a health ministry panel's report citing its low cost-effectiveness. Based on the assessment report, the ministry is expected to cut the official price of the drug by up to 15 pct from the current level...
With Beyoncé's Grammy Wins, Black Women in Country Are Finally Getting Their Due
February 17, 2025
Bad Bunny's "Debí Tirar Más Fotos" Tells Puerto Rico's History
February 17, 2025
Comments 0